![]() |
市场调查报告书
商品编码
1679329
温控药品包装解决方案市场预测至 2030 年:按包装类型、温度范围、材料、负载容量、应用和地区进行的全球分析Temperature Controlled Pharma Packaging Solutions Market Forecasts to 2030 - Global Analysis By Packaging Type, Temperature Range, Material, Payload Capacity, Application and By Geography |
根据 Stratistics MRC 的数据,全球温控药品包装解决方案市场预计在 2024 年将达到 49.1 亿美元,到 2030 年将达到 72.9 亿美元,预测期内的复合年增长率为 6.8%。
温控药品包装解决方案是专门设计用于在运输和储存过程中维持药品特定温度范围的系统。这些解决方案对于保护温度敏感药品、疫苗、生技药品和其他医疗产品的完整性和有效性至关重要。这些解决方案包括绝缘包装、主动冷却或加热系统以及温度监控设备,以确保符合法规标准。
生物製药需求不断成长
生物製药需求的成长主要是由于慢性病的增加、人口老化和生物技术的进步。这些因素要求高效、可靠且合规的包装解决方案,以在整个供应链中保持生物製药的功效和安全性。随着个人化医疗的成长,对确保温度控制的专门包装的需求变得更加重要。此外,生物製药储存和运输的监管标准日益严格,进一步增加了对高品质包装解决方案的需求。
包装和运输成本高
在运输过程中保持最佳温度所需的特殊材料和技术会导致成本增加。中小型製药公司尤其可能难以承担这些成本,进而影响其竞争力。此外,需要复杂的监控系统来确保遵守监管标准,这也增加了经济负担。温度敏感产品还会增加整个供应链的成本,包括储存、处理和最后一英里的交付。这些因素可能会限制温控包装解决方案的采用,尤其是在价格敏感的市场。
慢性病增加
糖尿病、心血管疾病和癌症等慢性病的增加为温控药品包装解决方案市场带来了巨大的机会。随着世界人口老化,这些疾病的盛行率预计会上升,导致对生物製药和其他温度敏感疗法的需求增加。此外,包装材料和设计的技术进步也为创新和市场成长提供了机会。此外,新兴市场医疗保健基础设施的扩张为温控包装供应商创造了新的机会。
供应链管理的复杂性
管理温度敏感的供应链需要先进的监控系统、可靠的基础设施和精确的协调。未能维持所需的温度范围可能导致财务损失、不符合法规以及产品品质不佳。此外,医药供应链的全球性涉及多个相关人员,包括製造商、物流供应商和医疗保健组织,这增加了其复杂性。即时可见性和可追溯性的需求进一步使供应链管理变得复杂。这些挑战可能会阻碍温度敏感药物的有效分销,进而影响患者安全和市场成长。
COVID-19 的影响
COVID-19 疫情对温控药品包装解决方案市场产生了重大影响。全球供应链中断和封锁措施影响了药品的生产和分销。然而,对温控包装解决方案的需求却激增。疫情也加速了数位监控系统的采用,以确保遵守监管标准并维护温度敏感产品的完整性。此外,对医疗保健基础设施和未来流行病应对措施的更多关注预计将推动市场长期成长。
预计预测期内,主动包装部分将成长至最大的部分。
预计预测期内,主动包装部分将占据最大的市场占有率。冷藏货柜和温控箱等主动包装解决方案提供了即时温度监控和控制等先进功能。对生技药品和个人化医疗的需求不断增长,进一步推动了主动包装解决方案的采用。此外,主动包装技术的进步(包括可重复使用和永续的选择)也促进了市场的成长。
预计预测期内生物製药领域将以最高的复合年增长率成长。
由于对生物製药和个人化医疗的需求不断增加,预计生物製药领域将在预测期内见证最高成长率。慢性病的增加和生物技术的进步正在推动对生物製药的需求,从而增加了对专业包装的需求。此外,监管机构越来越重视确保这些敏感产品的安全运输,从而推动了温控包装解决方案的采用。
在预测期内,由于製药和生物技术行业的扩张,预计亚太地区将占据最大的市场占有率。由于慢性病发病率上升和中产阶级人口增加,对温度敏感药物的需求不断增加,推动了市场的发展。此外,对改善医疗保健基础设施和增加获得优质医疗服务机会的关注也推动了温控包装解决方案的采用。
预计北美地区在预测期内将呈现最高的复合年增长率。这是由于严格的环境法规推动了对永续和环保包装解决方案的需求不断增加。电子商务的成长以及食品饮料行业的成长也促进了市场的成长。包装技术的进步以及对坚固耐用包装以提高品牌吸引力的关注也在推动创新包装解决方案的采用。
According to Stratistics MRC, the Global Temperature Controlled Pharma Packaging Solutions Market is accounted for $4.91 billion in 2024 and is expected to reach $7.29 billion by 2030 growing at a CAGR of 6.8% during the forecast period. Temperature-controlled pharma packaging solutions are specialized systems designed to maintain specific temperature ranges for pharmaceutical products during transportation and storage. These solutions are essential for safeguarding the integrity and efficacy of temperature-sensitive drugs, vaccines, biologics, and other healthcare products. They include insulated packaging, active cooling or heating systems, and temperature monitoring devices that ensure compliance with regulatory standards.
Rising demand for biopharmaceuticals
The rising demand for biopharmaceuticals is primarily driven by the increase in chronic diseases, aging populations, and advancements in biotechnology. These factors necessitate efficient, reliable, and compliant packaging solutions to maintain the efficacy and safety of biopharmaceutical products throughout the supply chain. With the growth in personalized medicine, the need for specialized packaging that ensures temperature control has become more critical. Additionally, regulatory standards for the storage and transportation of biopharmaceuticals are becoming more stringent, further driving the demand for high-quality packaging solutions.
High packaging and transportation costs
Specialized materials and technologies required for maintaining optimal temperatures during transit contribute to the increased costs. Small and medium-sized pharmaceutical companies, in particular, may find it difficult to bear these expenses, impacting their competitiveness. Furthermore, the need for advanced monitoring systems to ensure compliance with regulatory standards adds to the financial burden. The overall supply chain costs, including storage, handling, and last-mile delivery, are also higher for temperature-sensitive products. These factors can limit the widespread adoption of temperature-controlled packaging solutions, especially in price-sensitive markets.
Growing incidences of chronic diseases
The growing incidences of chronic diseases such as diabetes, cardiovascular diseases, and cancer present a significant opportunity for the Temperature Controlled Pharma Packaging Solutions Market. As the global population ages, the prevalence of these conditions is expected to rise, leading to increased demand for biopharmaceuticals and other temperature-sensitive treatments. Technological advancements in packaging materials and designs also offer opportunities for innovation and market growth. Additionally, the expanding healthcare infrastructure in emerging markets is creating new opportunities for temperature-controlled packaging providers.
Complexity in supply chain management
Advanced monitoring systems, reliable infrastructure, and exact coordination are necessary for managing a temperature-sensitive supply chain. Failure to maintain the necessary temperature ranges may lead to financial losses, non-compliance with regulations, and impaired product quality. Additionally, the global nature of the pharmaceutical supply chain involves multiple stakeholders, including manufacturers, logistics providers, and healthcare institutions, adding to the complexity. The need for real-time visibility and traceability further complicates the supply chain management. These challenges can hinder the efficient distribution of temperature-sensitive pharmaceuticals, impacting patient safety and market growth.
Covid-19 Impact
The Covid-19 pandemic significantly impacted the Temperature Controlled Pharma Packaging Solutions Market. The global supply chain disruptions and lockdown measures affected the production and distribution of pharmaceutical products. However, the demand for temperature-controlled packaging solutions surged. The pandemic also accelerated the adoption of digital monitoring systems to ensure compliance with regulatory standards and maintain the integrity of temperature-sensitive products. Additionally, the increased focus on healthcare infrastructure and preparedness for future pandemics is expected to drive long-term growth in the market.
The active packaging segment is expected to be the largest during the forecast period
The active packaging segment is expected to account for the largest market share during the forecast period. Active packaging solutions, such as refrigerated containers and temperature-controlled boxes, offer advanced features like real-time temperature monitoring and control. The growing demand for biologics and personalized medicine further drives the adoption of active packaging solutions. Additionally, advancements in active packaging technologies, including reusable and sustainable options, contribute to market growth.
The biopharmaceuticals segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the biopharmaceuticals segment is predicted to witness the highest growth rate, due to the increasing demand for biologic drugs and personalized medicine. The rise in chronic diseases and advancements in biotechnology are driving the demand for biopharmaceuticals, thereby boosting the need for specialized packaging. Additionally, regulatory agencies' focus on ensuring the safe transportation of these sensitive products is promoting the adoption of temperature-controlled packaging solutions.
During the forecast period, Asia Pacific region is expected to hold the largest market share, due to the region's expanding pharmaceutical and biotechnology industries. The increasing demand for temperature-sensitive pharmaceuticals, driven by the rising prevalence of chronic diseases and a growing middle-class population, is boosting the market. Additionally, the region's focus on improving healthcare infrastructure and expanding access to quality healthcare is driving the adoption of temperature-controlled packaging solutions.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to the rising demand for sustainable and eco-friendly packaging solutions, in line with strict environmental regulations. The rise in e-commerce and the growing food and beverage sector further contribute to market growth. The advancements in packaging technology and the emphasis on strong, durable packaging to improve brand appeal are also driving the adoption of innovative packaging solutions.
Key players in the market
Some of the key players profiled in the Temperature Controlled Pharma Packaging Solutions Market include Sonoco Products Company, Cold Chain Technologies, LLC, Va-Q-Tec AG, Pelican BioThermal LLC, Softbox Systems, Sofrigam SA, DGP Intelsius GmbH, Inmark, LLC, Envirotainer AB, FedEx Corporation, United Parcel Service, Inc. (UPS), AmerisourceBergen Corporation, Mondi Group, Snyder Industries, and H.B. Fuller Company.
In December 2024, Sonoco Products Company announced it has entered into an agreement to sell its Thermoformed and Flexibles Packaging business to TOPPAN Holdings Inc. for approximately $1.8 billion on a cash-free and debt-free basis and subject to customary adjustments.
In October 2024, Cold Chain Technologies ("CCT"), a leading global provider of advanced thermal packaging and digital monitoring solutions for the transportation of temperature-sensitive life sciences products, announced it has acquired Tower Cold Chain ("Tower"), a global provider of advanced passive reusable cold chain solutions. Terms of the transaction were not disclosed.